Commons Capital’s Fulgent Genetics FLGT Stock Holding History

Commons Capital’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,581	Closed	-$99K	–	122
2022 Q1	$99K	Sell	1,581 -1,019	-39%	-$67.1K	0.11%	140
2021 Q4	$262K	Buy	+2,600	New	+$229K	0.26%	83

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commons Capital's FLGT Position: Q2 2022 in Review

Commons Capital sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 1,581 shares — an estimated $99K sold.

Commons Capital first reported a position in FLGT in Q4 2021 and held it in 2 quarters. The position peaked at $262K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

Commons Capital reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
Commons Capital sold 1,581 Fulgent Genetics shares in Q2 2022, an estimated $99K.
Commons Capital first reported a position in Fulgent Genetics in Q4 2021 and held it in 2 quarters.
Commons Capital's Fulgent Genetics position peaked at $262K in Q4 2021.
262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Commons Capital's 13F filing for Q2 2022, filed 9 Aug 2022.